Serum 25(oH)D level in patients with CoVID-19

Vitamin D study #60 of 131 Meta Analysis

12/31 Analysis of outcomes based on serum levels

Karonova et al., Infectology, doi:10.22625/2072-6732-2020-12-3-21-27 (Peer Reviewed)
Serum 25(oH)D level in patients with CoVID-19

Source PDF Share Tweet

Retrospective 80 COVID-19 patients showing low vitamin D levels associated with severity and mortality.

Karonova et al., 12/31/2020, retrospective, Russia, Europe, peer-reviewed, 3 authors.

risk of death, 79.4% lower, RR 0.21, p = 0.07, high D levels 1 of 23 (4.3%), low D levels 12 of 57 (21.1%), odds ratio converted to relative risk, >20ng/ml.

risk of COVID-19 severe case, 71.1% lower, RR 0.29, p = 0.02, high D levels 3 of 23 (13.0%), low D levels 22 of 57 (38.6%), odds ratio converted to relative risk, >20ng/ml.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.

All 131 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit